Type outcomes endometrial cancer vulvar neoplasms. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy6

Endometrium Cell Line, Tumor Tumor Cells, Cultured Myometrium Lymph Nodes Pelvis

Organisms1

Diseases76

Vulvar Neoplasms Endometrial Neoplasms Carcinoma, Endometrioid Neoplasms Endometrial Hyperplasia Pancreatic Neoplasms Ovarian Neoplasms Uterine Neoplasms Neoplasm Invasiveness Breast Neoplasms Lung Neoplasms Adenocarcinoma Cystadenocarcinoma, Serous Carcinoma Genital Neoplasms, Female Neoplasms, Multiple Primary Prostatic Neoplasms Neoplasm Metastasis Neoplasms, Second Primary Colonic Neoplasms Genetic Predisposition to Disease Neoplasm Recurrence, Local Stomach Neoplasms Colorectal Neoplasms, Hereditary Nonpolyposis Adenocarcinoma, Clear Cell Cystadenocarcinoma, Papillary Skin Neoplasms Colorectal Neoplasms Uterine Cervical Neoplasms Neoplasms, Cystic, Mucinous, and Serous Disease Progression Adenocarcinoma, Mucinous Kidney Neoplasms Liver Neoplasms Adenocarcinoma, Papillary Thyroid Neoplasms Urinary Bladder Neoplasms Carcinoma, Squamous Cell Neoplasms, Hormone-Dependent Mixed Tumor, Mullerian Carcinoma, Papillary Gastrointestinal Neoplasms Neoplasms, Radiation-Induced Neoplasms, Glandular and Epithelial Precancerous Conditions Bone Neoplasms Cell Transformation, Neoplastic Rectal Neoplasms Vaginal Neoplasms Microsatellite Instability Uterine Hemorrhage Carcinosarcoma Mouth Neoplasms Carcinoma, Pancreatic Ductal Neoplasms, Experimental Carcinoma, Non-Small-Cell Lung Obesity Testicular Neoplasms Esophageal Neoplasms Adenoma Recurrence Head and Neck Neoplasms Peritoneal Neoplasms Mixed Tumor, Mesodermal Carcinoma, Adenosquamous Myeloproliferative Disorders Neovascularization, Pathologic Postoperative Complications Pelvic Neoplasms Lymphoma Intestinal Neoplasms Cystadenoma Hematologic Neoplasms Parotid Neoplasms Polyps Appendiceal Neoplasms

Chemicals and Drugs47

Tumor Markers, Biological Neoplasm Proteins Tamoxifen Estrogens DNA, Neoplasm Receptors, Progesterone Antineoplastic Agents, Hormonal Progestins Receptors, Estrogen Antineoplastic Agents RNA, Messenger Antigens, Neoplasm Estrogen Antagonists Contraceptives, Oral PTEN Phosphohydrolase MutS Homolog 2 Protein Cancer Vaccines Estrogen Receptor alpha Tumor Suppressor Protein p53 Estrogen Receptor Modulators RNA, Small Interfering Selective Estrogen Receptor Modulators Receptor, erbB-2 Nuclear Proteins Tumor Suppressor Proteins Paclitaxel DNA-Binding Proteins RNA, Neoplasm Proto-Oncogene Proteins Adaptor Proteins, Signal Transducing Proto-Oncogene Proteins c-akt Cisplatin MicroRNAs Antibodies, Monoclonal Estradiol Anticarcinogenic Agents Toremifene TOR Serine-Threonine Kinases Prostate-Specific Antigen Raloxifene Arylsulfotransferase CA-125 Antigen Ki-67 Antigen Antineoplastic Agents, Phytogenic Contraceptives, Oral, Hormonal Phytoestrogens Fluorouracil

Analytical, Diagnostic and Therapeutic Techniques and Equipment70

Treatment Outcome Prognosis Neoplasm Staging Risk Factors Retrospective Studies Early Detection of Cancer Hysterectomy Follow-Up Studies Prospective Studies Case-Control Studies Survival Rate Risk Survival Analysis Immunohistochemistry Risk Assessment Odds Ratio Cohort Studies Pregnancy Outcome Incidence Registries Estrogen Replacement Therapy Logistic Models Kaplan-Meier Estimate Reverse Transcriptase Polymerase Chain Reaction Multivariate Analysis Neoplasm Grading Salpingectomy Predictive Value of Tests Antineoplastic Combined Chemotherapy Protocols Sensitivity and Specificity Body Mass Index Gene Expression Profiling Combined Modality Therapy Disease-Free Survival Blotting, Western Confidence Intervals Neoplasm Transplantation SEER Program Chemotherapy, Adjuvant Lymph Node Excision Xenograft Model Antitumor Assays Immunoenzyme Techniques Polymerase Chain Reaction Reproducibility of Results Oligonucleotide Array Sequence Analysis Hormone Replacement Therapy Radiotherapy, Adjuvant Clinical Trials as Topic Tissue Array Analysis Neoplasms, Experimental Obesity Gynecologic Surgical Procedures Molecular Targeted Therapy Biopsy Questionnaires Chi-Square Distribution Radiotherapy Tomography, X-Ray Computed Proportional Hazards Models Transplantation, Heterologous Drug Screening Assays, Antitumor Genetic Testing Tumor Burden DNA Mutational Analysis Dilatation and Curettage Laparoscopy Pilot Projects Transfection Randomized Controlled Trials as Topic Regression Analysis

Psychiatry and Psychology1

Phenomena and Processes46

Gene Expression Regulation, Neoplastic Risk Odds Ratio Postmenopause Genetic Predisposition to Disease Pregnancy Outcome Time Factors Mutation Genotype Sensitivity and Specificity DNA Methylation Body Mass Index Cell Proliferation Germ-Line Mutation Drug Resistance, Neoplasm Polymorphism, Genetic Menopause Apoptosis Microsatellite Repeats Gene Silencing Cell Growth Processes Pregnancy Parity Premenopause Microsatellite Instability Obesity Dose-Response Relationship, Drug Down-Regulation Cell Survival Cell Division Chi-Square Distribution Signal Transduction Diet Genes, Tumor Suppressor Cell Cycle Promoter Regions, Genetic Polymorphism, Single Nucleotide Alleles DNA Mismatch Repair Cell Movement Base Sequence Genes, Neoplasm Phenotype Gene Expression Up-Regulation Transfection

Disciplines and Occupations2

Outcome Assessment (Health Care)Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena4

Quality of Life National Cancer Institute (U.S.)Age Distribution Survival

Technology, Industry, Agriculture1

Humanities1

Quality of Life

Information Science6

Survival Rate Incidence Registries SEER Program Questionnaires Base Sequence

Named Groups2

Survivors Infant, Newborn

Health Care39

Treatment Outcome Risk Factors Retrospective Studies Outcome Assessment (Health Care)Follow-Up Studies Prospective Studies Case-Control Studies Survival Rate Risk Survival Analysis Risk Assessment Odds Ratio Cohort Studies Incidence Registries Age Factors Logistic Models Kaplan-Meier Estimate Multivariate Analysis Predictive Value of Tests Sensitivity and Specificity Body Mass Index Disease-Free Survival Confidence Intervals SEER Program Reproducibility of Results Outcome and Process Assessment (Health Care)Parity Clinical Trials as Topic Questionnaires Chi-Square Distribution National Cancer Institute (U.S.)Proportional Hazards Models Genetic Testing Confounding Factors (Epidemiology)Age Distribution Pilot Projects Randomized Controlled Trials as Topic Regression Analysis

Geographicals5

United States Sweden China Japan Italy

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Vulvar Neoplasms Endometrial Neoplasms Carcinoma, Endometrioid Treatment Outcome Neoplasms Endometrial Hyperplasia Pancreatic Neoplasms Prognosis Ovarian Neoplasms Neoplasm Staging Risk Factors Uterine Neoplasms Retrospective Studies Outcome Assessment (Health Care)Neoplasm Invasiveness Early Detection of Cancer Breast Neoplasms Hysterectomy Follow-Up Studies Endometrium Prospective Studies Lung Neoplasms Tumor Markers, Biological Adenocarcinoma Case-Control Studies Gene Expression Regulation, Neoplastic Survival Rate Risk Survival Analysis Cystadenocarcinoma, Serous Carcinoma Neoplasm Proteins Genital Neoplasms, Female Tamoxifen Cell Line, Tumor Neoplasms, Multiple Primary Immunohistochemistry Prostatic Neoplasms Risk Assessment Odds Ratio Neoplasm Metastasis Cohort Studies Estrogens Neoplasms, Second Primary Colonic Neoplasms Postmenopause Genetic Predisposition to Disease Neoplasm Recurrence, Local DNA, Neoplasm Pregnancy Outcome Stomach Neoplasms Colorectal Neoplasms, Hereditary Nonpolyposis United States Incidence Adenocarcinoma, Clear Cell Registries Receptors, Progesterone Age Factors Cystadenocarcinoma, Papillary Skin Neoplasms Antineoplastic Agents, Hormonal Time Factors Colorectal Neoplasms Progestins Uterine Cervical Neoplasms Estrogen Replacement Therapy Neoplasms, Cystic, Mucinous, and Serous Receptors, Estrogen Logistic Models Disease Progression Kaplan-Meier Estimate Mice, Nude Reverse Transcriptase Polymerase Chain Reaction Antineoplastic Agents Mutation Multivariate Analysis Neoplasm Grading Genotype Adenocarcinoma, Mucinous Salpingectomy Kidney Neoplasms Predictive Value of Tests Antineoplastic Combined Chemotherapy Protocols Liver Neoplasms RNA, Messenger Sensitivity and Specificity Adenocarcinoma, Papillary DNA Methylation Thyroid Neoplasms Urinary Bladder Neoplasms Body Mass Index Antigens, Neoplasm Gene Expression Profiling Combined Modality Therapy Carcinoma, Squamous Cell Cell Proliferation Estrogen Antagonists Germ-Line Mutation Disease-Free Survival Drug Resistance, Neoplasm

No FAQ available that match "type outcomes endometrial cancer vulvar neoplasms"